Sanofi | SNY - Net Income




Sanofi reported EUR2.82B in Net Income for its fiscal quarter ending in September of 2024.

Net Income Change Date
AbbVie USD 1.56B 191M Sep/2024
Amgen USD 2.83B 2.08B Sep/2024
AstraZeneca USD 1.43B 498M Sep/2024
Bristol-Myers Squibb USD 1.21B 469M Sep/2024
Canopy Growth CAD -127140000 34.8M Jun/2024
Corcept Therapeutics USD 47.21M 11.72M Sep/2024
Drreddys Laboratories INR 12.55B 1.37B Sep/2024
Eli Lilly USD 970.3M 2B Sep/2024
Galapagos EUR -50430000 59.41M Sep/2024
Genmab DKK 1.27B 142M Sep/2024
GlaxoSmithKline GBP -58000000 1.23B Sep/2024
Glaxosmithkline GBP -58000000 1.23B Sep/2024
Indivior -107000000 154M Jun/2024
J&J USD 3.43B 737M Dec/2024
Merck USD 3.16B 2.3B Sep/2024
Novartis USD 3.19B 57M Sep/2024
Novartis USD 3.19B 501M Sep/2024
Pacira USD -143466000 162.36M Sep/2024
Perrigo USD -21000000 87.4M Sep/2024
Pfizer USD 4.46B 4.42B Sep/2024
Prestige Brands USD 54.38M 5.31M Sep/2024
Roche Holding CHF 3.13B 1.23B Jun/2024
Sanofi EUR 2.82B 1.7B Sep/2024
Sanofi EUR 2.82B 1.7B Sep/2024
Supernus Pharmaceuticals USD 38.5M 18.58M Sep/2024
UCB EUR 104M 72M Jun/2024
Zoetis USD 682M 58M Sep/2024